663 related articles for article (PubMed ID: 27102962)
1. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
3. Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis.
Babaev VR; Ding L; Zhang Y; May JM; Lin PC; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):598-607. PubMed ID: 26848161
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
[TBL] [Abstract][Full Text] [Related]
5. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
Kodama Y; Kisseleva T; Iwaisako K; Miura K; Taura K; De Minicis S; Osterreicher CH; Schnabl B; Seki E; Brenner DA
Gastroenterology; 2009 Oct; 137(4):1467-1477.e5. PubMed ID: 19549522
[TBL] [Abstract][Full Text] [Related]
6. Loss of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition.
Zhu L; Giunzioni I; Tavori H; Covarrubias R; Ding L; Zhang Y; Ormseth M; Major AS; Stafford JM; Linton MF; Fazio S
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1483-95. PubMed ID: 27365402
[TBL] [Abstract][Full Text] [Related]
7. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
8. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
Yu P; Qian AS; Chathely KM; Trigatti BL
Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-Associated Lipin-1 Enzymatic Activity Contributes to Modified Low-Density Lipoprotein-Induced Proinflammatory Signaling and Atherosclerosis.
Vozenilek AE; Navratil AR; Green JM; Coleman DT; Blackburn CMR; Finney AC; Pearson BH; Chrast R; Finck BN; Klein RL; Orr AW; Woolard MD
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):324-334. PubMed ID: 29217509
[TBL] [Abstract][Full Text] [Related]
10. CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.
Boulaftali Y; Owens AP; Beale A; Piatt R; Casari C; Lee RH; Conley PB; Paul DS; Mackman N; Bergmeier W
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):792-9. PubMed ID: 26988592
[TBL] [Abstract][Full Text] [Related]
11. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques.
Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH
Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.
Linton MF; Babaev VR; Huang J; Linton EF; Tao H; Yancey PG
Circ J; 2016 Oct; 80(11):2259-2268. PubMed ID: 27725526
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
[TBL] [Abstract][Full Text] [Related]
14. Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in Mice.
Nicolaou A; Zhao Z; Northoff BH; Sass K; Herbst A; Kohlmaier A; Chalaris A; Wolfrum C; Weber C; Steffens S; Rose-John S; Teupser D; Holdt LM
Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):247-257. PubMed ID: 28062509
[TBL] [Abstract][Full Text] [Related]
15. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
[TBL] [Abstract][Full Text] [Related]
16. Progranulin in the hematopoietic compartment protects mice from atherosclerosis.
Nguyen AD; Nguyen TA; Singh RK; Eberlé D; Zhang J; Abate JP; Robles A; Koliwad S; Huang EJ; Maxfield FR; Walther TC; Farese RV
Atherosclerosis; 2018 Oct; 277():145-154. PubMed ID: 30212683
[TBL] [Abstract][Full Text] [Related]
17. Combined Activities of JNK1 and JNK2 in Hepatocytes Protect Against Toxic Liver Injury.
Cubero FJ; Zoubek ME; Hu W; Peng J; Zhao G; Nevzorova YA; Al Masaoudi M; Bechmann LP; Boekschoten MV; Muller M; Preisinger C; Gassler N; Canbay AE; Luedde T; Davis RJ; Liedtke C; Trautwein C
Gastroenterology; 2016 Apr; 150(4):968-81. PubMed ID: 26708719
[TBL] [Abstract][Full Text] [Related]
18. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR
Thompson D; Morrice N; Grant L; Le Sommer S; Lees EK; Mody N; Wilson HM; Delibegovic M
Clin Sci (Lond); 2017 Oct; 131(20):2489-2501. PubMed ID: 28899902
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.
Ren B; Van Kampen E; Van Berkel TJ; Cruickshank SM; Van Eck M
Atherosclerosis; 2017 Jan; 256():35-46. PubMed ID: 27998825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]